该基金股票持仓前十分别为：百利天恒、泽璟制药-U、热景生物、诺诚健华-U、百济神州-U、益方生 物-U、一品红、惠泰医疗、舒泰神、海思科。前十持仓占比合计60.20%。 来源：金融界 金融界2025年8月24日消息，富国医疗保健行业混合A(000220) 最新净值4.0390元，该基金近一周收益 率-0.44%，近3个月收益率25.94%，今年来收益率44.40%。 富国医疗保健行业混合A基金成立于2013年8月7日，基金经理孙笑悦，截至2025年6月30日，富国医疗 保健行业混合A规模9.72亿元。 ...

该基金股票持仓前十分别为：百利天恒、泽璟制药-U、热景生物、诺诚健华-U、百济神州-U、益方生 物-U、一品红、惠泰医疗、舒泰神、海思科。前十持仓占比合计60.20%。 来源：金融界 富国医疗保健行业混合A基金成立于2013年8月7日，基金经理孙笑悦，截至2025年6月30日，富国医疗 保健行业混合A规模9.72亿元。 金融界2025年8月17日消息，富国医疗保健行业混合A(000220) 最新净值4.0570元，该基金近一周收益率 3.02%，近3个月收益率34.43%，今年来收益率45.05%。 ...

Group 1 - The core viewpoint of the article highlights the performance and key details of the Fortune Healthcare Industry Mixed A Fund, which has shown significant returns in recent months [1] - The fund's latest net value is 3.9380 yuan, with a weekly return of -2.62%, a three-month return of 28.69%, and a year-to-date return of 40.79% [1] - The fund was established on August 7, 2013, and as of June 30, 2025, it has a total scale of 972 million yuan [1] Group 2 - The top ten stock holdings of the fund include companies such as Baili Tianheng, Zexin Pharmaceutical-U, and Hotgen Biotech, with the top ten holdings accounting for a total of 60.20% of the portfolio [1]

Group 1 - The core viewpoint of the article highlights the performance of the Fortune Healthcare Industry Mixed A Fund, which has shown significant returns over various time frames [1] - As of August 3, 2025, the fund's latest net value is 4.0440 yuan, with a weekly return of 4.42%, a three-month return of 27.01%, and a year-to-date return of 44.58% [1] - The fund was established on August 7, 2013, and as of June 30, 2025, it has a total scale of 972 million yuan [1] Group 2 - The top ten stock holdings of the fund include companies such as Baillie Gifford, Zai Lab, Hotgen Biotech, and Innovent Biologics, with the top ten holdings accounting for a total of 60.20% of the fund's portfolio [1]

Group 1 - The core viewpoint of the news is that the FuGuo Healthcare Industry Mixed A fund has experienced a decline of 2.04% on June 19, with a cumulative drop of 9.9% over the last five trading days, and its latest net value is 3.37 yuan [1] - The fund was established in August 2013, with a total fund size of 932 million yuan and a cumulative return of 236.90% since inception [1] - As of the end of 2024, the fund's holder structure shows that institutional investors hold 0.07 million shares, accounting for 2.33% of the total, while individual investors hold 31.3 million shares, making up 97.67% of the total [1] Group 2 - As of March 31, 2025, the top ten holdings of the FuGuo Healthcare Industry Mixed A fund account for a total of 56.63%, with the largest holding being Baili Tianheng at 9.91% [2] - Other significant holdings include Zexing Pharmaceutical-U (7.27%), DR Huatai Medical (5.70%), Aier Eye Hospital (5.46%), and Aibo Medical (5.14%) [2] - The fund manager, Ms. Sun Xiaoyue, has a master's degree and has held various positions in the pharmaceutical analysis field since joining FuGuo Fund Management in August 2018 [1]